Allianz Biotechnologie A EUR/ DE0008481862 /
| NAV12/6/2023 | Chg.+0.8200 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 192.8800EUR | +0.43% | paying dividend | Equity | Allianz Gl.Investors ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 12/7/2023 | Public WebStation Live Factsheet | 2023 | English | - |
| 11/29/2023 | PREN20231129-0002009593.pdf | 2023 | English | 300.42 KB |
| 11/29/2023 | PRDE20231129-0002008435.pdf | 2023 | German | 264.48 KB |
| 9/29/2023 | Prospectus | 2023 | German | 560.09 KB |
| 6/30/2023 | Semi-annual report | 2023 | English | 127.19 KB |
| 6/30/2023 | Semi-annual report | 2023 | German | 115.13 KB |
| 12/31/2022 | Account statment | 2022 | English | 185.10 KB |
| 12/31/2022 | Account statment | 2022 | German | 173.02 KB |
| 9/13/2022 | Key Investor Information | 2022 | English | 77.21 KB |
| 9/13/2022 | Key Investor Information | 2022 | German | 77.64 KB |
| 7/25/2022 | Prospectus | 2022 | English | 650.16 KB |